CStone Pharmaceuticals
HKEX:2616
CStone Pharmaceuticals
HKEX:2616
Price:
7.13
HKD
-2.06%
Market Closed
Market Cap:
HK$10.5B
Wall Street
Price Targets
Price Targets Summary
CStone Pharmaceuticals
CStone Pharmaceuticals
Wall Street analysts forecast CStone Pharmaceuticals stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
CStone Pharmaceuticals
is 14.41 HKD
with a low forecast of 8.34 HKD and a high forecast of 21 HKD.
Lowest
Price Target
8.34
HKD
17% Upside
Average
Price Target
14.41
HKD
102% Upside
Highest
Price Target
21
HKD
195% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CStone Pharmaceuticals's stock price target?
Price Target
14.41
HKD
14.41
HKD
According to Wall Street analysts, the average 1-year price target for
CStone Pharmaceuticals
is 14.41 HKD
with a low forecast of 8.34 HKD and a high forecast of 21 HKD.
What is CStone Pharmaceuticals's Revenue forecast?
Projected CAGR
66%
66%
The
compound annual growth rate
of CStone Pharmaceuticals's revenue for the next 3 years is
66%.
